LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].

    Tawfik, Haytham O / El-Moselhy, Tarek F / El-Din, Nabaweya S / El-Hamamsy, Mervat H

    Bioorganic & medicinal chemistry

    2020  Band 28, Heft 19, Seite(n) 115687

    Sprache Englisch
    Erscheinungsdatum 2020-08-18
    Erscheinungsland England
    Dokumenttyp Published Erratum
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2020.115687
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors.

    Tawfik, Haytham O / El-Moselhy, Tarek F / El-Din, Nabaweya S / El-Hamamsy, Mervat H

    Bioorganic & medicinal chemistry

    2019  Band 27, Heft 23, Seite(n) 115126

    Abstract: A series of twenty-one 3,4-dihydropyrimidine derivatives bearing the heterocyclic 1,3-benzodioxole at position 4 in addition to different substituents at positions 2, 3 and 5 were designed and synthesized as monastrol analogs. The novel synthesized ... ...

    Abstract A series of twenty-one 3,4-dihydropyrimidine derivatives bearing the heterocyclic 1,3-benzodioxole at position 4 in addition to different substituents at positions 2, 3 and 5 were designed and synthesized as monastrol analogs. The novel synthesized compounds were screened for their cytotoxic activity towards 60 cancer cell lines according to NCI (USA) protocol. Compounds 10b and 15 showed the best antitumor activity against most cell lines. Compound 15 was subsequently tested in 5-doses mode and displayed high selectivity towards CNS, prostate and leukemia subpanel with selectivity ratios of 22.30, 15.38 and 12.56, respectively at GI
    Mesh-Begriff(e) Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Cell Cycle/drug effects ; Cell Line, Tumor ; Drug Design ; Drug Screening Assays, Antitumor ; HEK293 Cells ; Humans ; Kinesin/antagonists & inhibitors ; Kinesin/metabolism ; Molecular Docking Simulation ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Pyrimidines/chemistry ; Pyrimidines/pharmacology
    Chemische Substanzen 1,4-dihydropyrimidine ; Antineoplastic Agents ; KIF11 protein, human ; Pyrimidines ; Kinesin (EC 3.6.4.4)
    Sprache Englisch
    Erscheinungsdatum 2019-10-18
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2019.115126
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].

    Tawfik, Haytham O / El-Moselhy, Tarek F / El-Din, Nabaweya S / El-Hamamsy, Mervat H

    Bioorganic & medicinal chemistry

    2019  Band 28, Heft 2, Seite(n) 115255

    Sprache Englisch
    Erscheinungsdatum 2019-12-17
    Erscheinungsland England
    Dokumenttyp Published Erratum
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2019.115255
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang